Trials / Completed
CompletedNCT01583738
Effect of V0251 in Acute Vertigo
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 132 (actual)
- Sponsor
- Pierre Fabre Medicament · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Assessment of efficacy and tolerance of a new anti-dizziness drug in acute vertigo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | V0251 | single dose |
| DRUG | placebo | single dose |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2012-04-24
- Last updated
- 2014-10-30
Locations
40 sites across 5 countries: Czechia, France, Germany, Hungary, Spain
Source: ClinicalTrials.gov record NCT01583738. Inclusion in this directory is not an endorsement.